Your browser doesn't support javascript.
Biomaterials and nanomaterials for sustained release vaccine delivery.
Luzuriaga, Michael A; Shahrivarkevishahi, Arezoo; Herbert, Fabian C; Wijesundara, Yalini H; Gassensmith, Jeremiah J.
  • Luzuriaga MA; Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Shahrivarkevishahi A; Division of Medical Sciences, Harvard Medical School, Boston, Massachusetts, USA.
  • Herbert FC; Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardon, Texas, USA.
  • Wijesundara YH; Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardon, Texas, USA.
  • Gassensmith JJ; Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardon, Texas, USA.
Wiley Interdiscip Rev Nanomed Nanobiotechnol ; 13(6): e1735, 2021 11.
Article in English | MEDLINE | ID: covidwho-1283762
ABSTRACT
Vaccines are considered one of the most significant medical advancements in human history, as they have prevented hundreds of millions of deaths since their discovery; however, modern travel permits disease spread at unprecedented rates, and vaccine shortcomings like thermal sensitivity and required booster shots have been made evident by the COVID-19 pandemic. Approaches to overcoming these issues appear promising via the integration of vaccine technology with biomaterials, which offer sustained-release properties and preserve proteins, prevent conformational changes, and enable storage at room temperature. Sustained release and thermal stabilization of therapeutic biomacromolecules is an emerging area that integrates material science, chemistry, immunology, nanotechnology, and pathology to investigate different biocompatible materials. Biomaterials, including natural sugar polymers, synthetic polyesters produced from biologically derived monomers, hydrogel blends, protein-polymer blends, and metal-organic frameworks, have emerged as early players in the field. This overview will focus on significant advances of sustained release biomaterial in the context of vaccines against infectious disease and the progress made towards thermally stable "single-shot" formulations. This article is categorized under Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biocompatible Materials / Vaccines / Delayed-Action Preparations / Nanostructures Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Year: 2021 Document Type: Article Affiliation country: Wnan.1735

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Biocompatible Materials / Vaccines / Delayed-Action Preparations / Nanostructures Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Year: 2021 Document Type: Article Affiliation country: Wnan.1735